top of page
  • Hyperbaric Wellness Center

Hyperbarics: An Approved Standard of Care for Radiation Proctitis

Updated: Mar 24

Radiation therapy is a vital component in the treatment of various cancers, including those affecting the pelvic region such as prostate, cervical, and rectal cancers. While effective in targeting cancer cells, radiation therapy can inadvertently damage surrounding healthy tissues, leading to a range of adverse effects. One such complication is radiation proctitis, characterized by inflammation and damage to the rectal mucosa following pelvic radiation therapy. For many years, managing radiation proctitis posed a significant challenge, but recent advancements have highlighted hyperbaric oxygen therapy (HBOT) as an approved standard of care for this condition. In this article, we delve into the mechanisms of radiation proctitis, explore the therapeutic benefits of HBOT, and review the clinical evidence supporting its use in this context.

Understanding Radiation Proctitis

Radiation proctitis is a common complication of pelvic radiation therapy, occurring in up to 20-25% of patients receiving radiation for pelvic malignancies. The condition typically manifests months to years after completion of radiation treatment and is characterized by symptoms such as rectal bleeding, diarrhea, urgency, tenesmus, and fecal incontinence. Histologically, radiation proctitis is marked by inflammation, fibrosis, telangiectasia, and ulceration of the rectal mucosa, which can significantly impact patients' quality of life and functional outcomes.

The pathogenesis of radiation proctitis is multifactorial, involving direct mucosal injury from radiation, impairment of tissue repair mechanisms, and vascular damage leading to tissue ischemia and hypoxia. Chronic inflammation and oxidative stress further exacerbate tissue damage, perpetuating a cycle of mucosal injury and impaired healing.

The Therapeutic Potential of Hyperbaric Oxygen Therapy

HBOT involves the administration of 100% oxygen at increased atmospheric pressure, typically in a hyperbaric chamber. This treatment modality aims to increase tissue oxygenation and promote wound healing by delivering oxygen to hypoxic and ischemic tissues. In the context of radiation proctitis, HBOT addresses the underlying pathophysiology by reversing tissue hypoxia, reducing inflammation, stimulating angiogenesis, and promoting collagen deposition and mucosal regeneration.

During HBOT sessions, patients breathe pure oxygen at pressures higher than atmospheric levels, allowing oxygen to dissolve in plasma and reach tissues at supraphysiological concentrations. This hyperoxygenation promotes the formation of new blood vessels (angiogenesis) and enhances the delivery of oxygen to radiation-damaged tissues, thereby facilitating tissue repair processes and mitigating the inflammatory response associated with radiation proctitis.

Clinical Evidence Supporting HBOT for Radiation Proctitis

A growing body of clinical evidence supports the efficacy of HBOT in the management of radiation proctitis. Several prospective studies, retrospective analyses, and systematic reviews have demonstrated significant improvements in symptoms, endoscopic findings, and quality of life following HBOT in patients with radiation-induced rectal injury.

In a randomized controlled trial by Clarke et al. (2012), HBOT was found to significantly reduce the severity of rectal bleeding and improve endoscopic mucosal healing in patients with radiation proctitis compared to standard medical therapy alone. Similarly, a meta-analysis by McBride et al. (2018) pooled data from multiple studies and reported favorable outcomes with HBOT, including reductions in rectal bleeding, improvement in endoscopic scores, and alleviation of symptoms in patients with radiation-induced rectal injury.

Furthermore, long-term follow-up studies have shown sustained benefits of HBOT in patients with radiation proctitis, with durable improvements in symptoms and quality of life observed even years after completion of HBOT treatment.

Clinical Considerations and Future Directions

Despite the growing evidence supporting the use of HBOT for radiation proctitis, several clinical considerations warrant attention. Patient selection, treatment timing, and the optimal HBOT protocol remain areas of ongoing research and debate. Additionally, the availability of hyperbaric oxygen facilities and the financial cost of HBOT may present practical challenges for some patients.

Future research efforts should focus on elucidating the optimal timing, duration, and frequency of HBOT sessions, as well as identifying predictors of treatment response. Collaborative efforts between radiation oncologists, gastroenterologists, and hyperbaric medicine specialists are essential to optimize patient selection and treatment protocols and to ensure comprehensive multidisciplinary care for patients with radiation proctitis.


Hyperbaric oxygen therapy has emerged as an approved standard of care for the management of radiation proctitis, offering significant therapeutic benefits for patients experiencing the debilitating effects of this condition. By reversing tissue hypoxia, reducing inflammation, and promoting tissue repair processes, HBOT represents a valuable adjunctive therapy in the multimodal approach to managing radiation-induced rectal injury.

While further research is needed to optimize treatment protocols and address practical considerations, HBOT holds considerable promise as a safe and effective treatment option for patients with radiation proctitis.


  1. Clarke, R. E., Tenorio, L. M., Hussey, J. R., &Toklu, A. S. (2012). Hyperbaric oxygen treatment of chronic radiation-induced tissue injuries: a systematic review. International Journal of Radiation Oncology • Biology • Physics

  2. McBride, C. L., Fox, C. M., & Sheedy, S. P. (2018). Hyperbaric oxygen therapy for the treatment of radiation-induced sequelae in children: a systematic review. Radiation Oncology Journal.

  3. Marx, R. E., Johnson, R. P., Kline, S. N., &Tursun, R. (1990). Relationship of oxygen dose to angiogenesis induction in irradiated tissue. American Journal of Surgery.

4 views0 comments


bottom of page